Literature DB >> 19342779

Crystallization and preliminary crystallographic analysis of fragaceatoxin C, a pore-forming toxin from the sea anemone Actinia fragacea.

A E Mechaly1, A Bellomio, K Morante, J M González-Mañas, D M A Guérin.   

Abstract

Sea anemones produce water-soluble toxins that have the ability to interact with cell membranes and form pores within them. The mechanism of pore formation is based on an initial binding step followed by oligomerization and membrane insertion. Although the final structure of the pore remains unclear, biochemical studies indicate that it consists of a tetramer with a functional radius of approximately 1.1 nm. Since four monomers seem to be insufficient to build a pore of this size, the currently accepted model suggests that lipids might also participate in its structure. In this work, the crystallization and preliminary crystallographic analysis of two crystal forms of fragaceatoxin C (FraC), a newly characterized actinoporin from Actinia fragacea, are described. The crystals diffracted up to 1.8 A resolution and the preliminary molecular-replacement solution supports an oligomeric structure of about 120 A in diameter.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342779      PMCID: PMC2664759          DOI: 10.1107/S1744309109007064

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  29 in total

1.  SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model.

Authors:  A A Vaguine; J Richelle; S J Wodak
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-01-01

2.  The equinatoxin N-terminus is transferred across planar lipid membranes and helps to stabilize the transmembrane pore.

Authors:  Katarina Kristan; Gabriella Viero; Peter Macek; Mauro Dalla Serra; Gregor Anderluh
Journal:  FEBS J       Date:  2007-01       Impact factor: 5.542

3.  Mechanism of the leakage induced on lipid model membranes by the hemolytic protein sticholysin II from the sea anemone Stichodactyla helianthus.

Authors:  V de los Rios; J M Mancheño; M E Lanio; M Oñaderra; J G Gavilanes
Journal:  Eur J Biochem       Date:  1998-03-01

4.  Cloning, sequencing, and expression of equinatoxin II.

Authors:  G Anderluh; J Pungercar; B Strukelj; P Macek; F Gubensek
Journal:  Biochem Biophys Res Commun       Date:  1996-03-18       Impact factor: 3.575

5.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

6.  Effects of lipid composition on membrane permeabilization by sticholysin I and II, two cytolysins of the sea anemone Stichodactyla helianthus.

Authors:  C A Valcarcel; M Dalla Serra; C Potrich; I Bernhart; M Tejuca; D Martinez; F Pazos; M E Lanio; G Menestrina
Journal:  Biophys J       Date:  2001-06       Impact factor: 4.033

7.  Molecular determinants of sphingomyelin specificity of a eukaryotic pore-forming toxin.

Authors:  Biserka Bakrac; Ion Gutiérrez-Aguirre; Zdravko Podlesek; Andreas F-P Sonnen; Robert J C Gilbert; Peter Macek; Jeremy H Lakey; Gregor Anderluh
Journal:  J Biol Chem       Date:  2008-04-28       Impact factor: 5.157

Review 8.  Sea anemone actinoporins: the transition from a folded soluble state to a functionally active membrane-bound oligomeric pore.

Authors:  J Alegre-Cebollada; M Oñaderra; J G Gavilanes; A Martínez del Pozo
Journal:  Curr Protein Pept Sci       Date:  2007-12       Impact factor: 3.272

9.  Pore formation by the sea anemone cytolysin equinatoxin II in red blood cells and model lipid membranes.

Authors:  G Belmonte; C Pederzolli; P Macek; G Menestrina
Journal:  J Membr Biol       Date:  1993-01       Impact factor: 1.843

Review 10.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14
View more
  7 in total

Review 1.  Sea anemone (Cnidaria, Anthozoa, Actiniaria) toxins: an overview.

Authors:  Bárbara Frazão; Vitor Vasconcelos; Agostinho Antunes
Journal:  Mar Drugs       Date:  2012-08-22       Impact factor: 6.085

2.  Structural and biophysical characterization of Bacillus thuringiensis insecticidal proteins Cry34Ab1 and Cry35Ab1.

Authors:  Matthew S Kelker; Colin Berry; Steven L Evans; Reetal Pai; David G McCaskill; Nick X Wang; Joshua C Russell; Matthew D Baker; Cheng Yang; J W Pflugrath; Matthew Wade; Tim J Wess; Kenneth E Narva
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

Review 3.  Actinoporins: From the Structure and Function to the Generation of Biotechnological and Therapeutic Tools.

Authors:  Santos Ramírez-Carreto; Beatriz Miranda-Zaragoza; Claudia Rodríguez-Almazán
Journal:  Biomolecules       Date:  2020-04-02

4.  Evaluating cytotoxic effects of recombinant fragaceatoxin C pore forming toxin against AML cell lines.

Authors:  Mahnaz Azadpour; Maedeh Karimian; Mohammad Hassan Kheirandish; Abolghasem Asadi-Saghandi; Mehdi Imani; Akram Astani; Hossein Zarei Jaliani
Journal:  Iran J Basic Med Sci       Date:  2018-09       Impact factor: 2.699

5.  Oligomerization of Sticholysins from Förster Resonance Energy Transfer.

Authors:  Juan Palacios-Ortega; Esperanza Rivera-de-Torre; Sara García-Linares; José G Gavilanes; Álvaro Martínez-Del-Pozo; J Peter Slotte
Journal:  Biochemistry       Date:  2021-01-14       Impact factor: 3.162

Review 6.  Sea Anemones, Actinoporins, and Cholesterol.

Authors:  Juan Palacios-Ortega; Diego Heras-Márquez; Rafael Amigot-Sánchez; Carmen García-Montoya; Carlos Torrijos; Diego Laxalde; José G Gavilanes; Sara García-Linares; Álvaro Martínez-Del-Pozo
Journal:  Int J Mol Sci       Date:  2022-08-07       Impact factor: 6.208

7.  Determination of the boundary lipids of sticholysins using tryptophan quenching.

Authors:  Juan Palacios-Ortega; Rafael Amigot-Sánchez; Carmen García-Montoya; Ana Gorše; Diego Heras-Márquez; Sara García-Linares; Álvaro Martínez-Del-Pozo; J Peter Slotte
Journal:  Sci Rep       Date:  2022-10-15       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.